Literature DB >> 16442912

Higher New York Heart Association classes and increased mortality and hospitalization in patients with heart failure and preserved left ventricular function.

Ali Ahmed1, Wilbert S Aronow, Jerome L Fleg.   

Abstract

BACKGROUND: The association between higher New York Heart Association (NYHA) class and outcomes in patients with heart failure and preserved systolic function is not well known.
METHODS: We performed a retrospective follow-up study of 988 patients with heart failure with ejection fraction > 45% who participated in the DIG trial. Using Cox proportional hazard models, we estimated risks and all-cause mortality, heart failure mortality, all-cause hospitalization, and hospitalization due to worsening heart failure during a median follow-up of 38.5 months.
RESULTS: Patients had a median age of 68 years; 41.2% were women and 13.9%, nonwhites. Overall, 23.4% of patients died, and 19.9% were hospitalized because of worsening heart failure. Proportion of patients with NYHA classes I, II, III, and IV were 19.9%, 58.0%, 20.9%, and 1.2%, respectively, and 14.7%, 21.1%, 35.9%, and 58.3%, respectively, died of all causes (P < .001 for trend). Respective rates for heart failure-related hospitalizations were 14.2%, 17.1%, 32.5%, and 33.3% (P < .001 for trend). Compared with NYHA class I patients, adjusted hazard ratios (HRs) for all-cause mortality for class II, III, and IV patients were 1.54 (95% CI 1.02-2.32, P = .042), 2.56 (95% CI 1.64-24.01, P < .001), and 8.46 (95% CI 3.57-20.03, P < .001), respectively. Respective adjusted HRs (95% CI) for hospitalization due to heart failure for class II, III, and IV patients were 1.16 (0.76-1.77) (P = .502), 2.27 (1.45-3.56) (P < .001), and 3.71 (1.25-11.02) (P = 018). New York Heart Association classes II through IV were also associated with higher risk of all-cause hospitalization.
CONCLUSION: Higher NYHA classes were associated with poorer outcomes in patients with heart failure and preserved systolic function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16442912      PMCID: PMC2771182          DOI: 10.1016/j.ahj.2005.03.066

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  17 in total

1.  Defining diastolic heart failure: a call for standardized diagnostic criteria.

Authors:  R S Vasan; D Levy
Journal:  Circulation       Date:  2000-05-02       Impact factor: 29.690

2.  The effect of digoxin on mortality and morbidity in patients with heart failure.

Authors: 
Journal:  N Engl J Med       Date:  1997-02-20       Impact factor: 91.245

3.  Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort.

Authors:  R S Vasan; M G Larson; E J Benjamin; J C Evans; C K Reiss; D Levy
Journal:  J Am Coll Cardiol       Date:  1999-06       Impact factor: 24.094

4.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

5.  Comparison of incidences of congestive heart failure in older African-Americans, Hispanics, and whites.

Authors:  W S Aronow; C Ahn; I Kronzon
Journal:  Am J Cardiol       Date:  1999-09-01       Impact factor: 2.778

6.  Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991.

Authors:  M Senni; C M Tribouilloy; R J Rodeheffer; S J Jacobsen; J M Evans; K R Bailey; M M Redfield
Journal:  Circulation       Date:  1998-11-24       Impact factor: 29.690

7.  Predictors of mortality in patients with heart failure and preserved systolic function in the Digitalis Investigation Group trial.

Authors:  R Christopher Jones; Gary S Francis; Michael S Lauer
Journal:  J Am Coll Cardiol       Date:  2004-09-01       Impact factor: 24.094

8.  Determination of vital status at the end of the DIG trial.

Authors:  Joseph F Collins; Cindy L Howell; R Anne Horney
Journal:  Control Clin Trials       Date:  2003-12

9.  Chronic congestive heart failure. Description and survival of 190 consecutive patients with a diagnosis of chronic congestive heart failure based on clinical signs and symptoms.

Authors:  B K Madsen; J F Hansen; K H Stokholm; J Brøns; D Husum; L S Mortensen
Journal:  Eur Heart J       Date:  1994-03       Impact factor: 29.983

10.  Prediction of mortality in mild to moderately symptomatic patients with left ventricular dysfunction. The role of the New York Heart Association classification, cardiopulmonary exercise testing, two-dimensional echocardiography and Holter monitoring.

Authors:  D Scrutinio; R Lagioia; A Ricci; M Clemente; L Boni; P Rizzon
Journal:  Eur Heart J       Date:  1994-08       Impact factor: 29.983

View more
  54 in total

1.  Oxidation and tyrosine phosphorylation: synergistic or antagonistic cues in protein tyrosine phosphatase.

Authors:  P Chiarugi; M L Taddei; G Ramponi
Journal:  Cell Mol Life Sci       Date:  2005-05       Impact factor: 9.261

Review 2.  Patient selection in heart failure with preserved ejection fraction clinical trials.

Authors:  Jacob P Kelly; Robert J Mentz; Alexandre Mebazaa; Adriaan A Voors; Javed Butler; Lothar Roessig; Mona Fiuzat; Faiez Zannad; Bertram Pitt; Christopher M O'Connor; Carolyn S P Lam
Journal:  J Am Coll Cardiol       Date:  2015-04-28       Impact factor: 24.094

Review 3.  Exercise And Heart Failure: Advancing Knowledge And Improving Care.

Authors:  Paulino Alvarez; Bashar Hannawi; Ashrith Guha
Journal:  Methodist Debakey Cardiovasc J       Date:  2016 Apr-Jun

4.  Outcomes in ambulatory chronic systolic and diastolic heart failure: a propensity score analysis.

Authors:  Ali Ahmed; Gilbert J Perry; Jerome L Fleg; Thomas E Love; David C Goff; Dalane W Kitzman
Journal:  Am Heart J       Date:  2006-11       Impact factor: 4.749

5.  Characteristics and outcomes of patients with advanced chronic systolic heart failure receiving care at the Veterans Affairs versus other hospitals: insights from the Beta-blocker Evaluation of Survival Trial (BEST).

Authors:  Linda G Jones; Mo-Kyung Sin; Fadi G Hage; Raya E Kheirbek; Charity J Morgan; Michael R Zile; Wen-Chih Wu; Prakash Deedwania; Gregg C Fonarow; Wilbert S Aronow; Sumanth D Prabhu; Ross D Fletcher; Ali Ahmed; Richard M Allman
Journal:  Circ Heart Fail       Date:  2014-12-05       Impact factor: 8.790

6.  Association between fluid balance and survival in critically ill patients.

Authors:  J Lee; E de Louw; M Niemi; R Nelson; R G Mark; L A Celi; K J Mukamal; J Danziger
Journal:  J Intern Med       Date:  2014-06-27       Impact factor: 8.989

7.  Patients' self-assessed functional status in heart failure by New York Heart Association class: a prognostic predictor of hospitalizations, quality of life and death.

Authors:  Richard Holland; Boika Rechel; Karolina Stepien; Ian Harvey; Iain Brooksby
Journal:  J Card Fail       Date:  2009-10-22       Impact factor: 5.712

8.  Surgical ventricular restoration: an operation to reverse remodeling - the basic science (part I).

Authors:  Ganesh Shanmugam; Imtiaz S Ali
Journal:  Curr Cardiol Rev       Date:  2009-11

Review 9.  [Aftercare of patients after MitraClip® implantation].

Authors:  A Schlitt; E Lubos; M Guha; C Hegeler-Molkewehrum; M Sudau; H Schmidt
Journal:  Herz       Date:  2016-06-27       Impact factor: 1.443

10.  Cardiac troponin I as prognostic marker in heart failure patients discharged from emergency department.

Authors:  Nicola Parenti; Silvia Bartolacci; Flavia Carle; Fanciulli Angelo
Journal:  Intern Emerg Med       Date:  2008-02-14       Impact factor: 3.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.